Skip to main content

AN2 Therapeutics Inc. Common Stock (ANTX)

About The Company

ANTX Stock Market Logo

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.

IPO Year Sector Industry
2022 Health Care Biotechnology: Pharmaceutical Preparations

AN2 Therapeutics Inc. (ANTX) Latest News

Company Contact & Address (ANTX)

Corporate Headquarters Phone Website
1800 EL CAMINO REAL SUITE D,
MENLO PARK,
California,
94027,
United States
+1 650 331-9090 Official ANTX Website

ANTX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ANTX

Jobs & Employment at AN2 Therapeutics Inc.

LinkedIn Company Page https://www.linkedin.com/company/an2-therapeutics-inc
Official Career & Employment Page See LinkedIn page for more employment & jobs details.

Related & Similar Stock Symbols

MFV Stock Market Price & News

MFV

MFS Special Value Trust Common Stock

TIG Stock Market Price & News

TIG

Trean Insurance Group Inc. Common Stock

ADRT Stock Market Price & News

ADRT

Ault Disruptive Technologies Corporation Common Stock